01 Oct 2013, BioSpectrum Bureau , BioSpectrum
New Delhi: India's finance ministry has released a statement announcing that the country's Foreign Investment Promotion Board (FIPB) cleared 15 Foreign Direct Investment (FDI) proposals worth $322.58 million.
These proposals, the statement said had been considered on August 27 by the board. The board recommended IDFC Trustee Company's proposal to set up an alternate investment fund for the consideration of the CCEA. The expected foreign inflow is $887.09 million.
Proposals by Jubilant Pharma Pte, Singapore, Lotus Surgical Specialities, Symbiotec Pharmalab and Advanced Enzyme Technologies were cleared by the board.